journal
https://read.qxmd.com/read/38344733/human-nephrogenesis-can-persist-beyond-40-postnatal-days-in-preterm-infants
#41
JOURNAL ARTICLE
James Carpenter, Sunitha Yarlagadda, Katherine A VandenHeuvel, Lili Ding, Meredith P Schuh
INTRODUCTION: Human nephrogenesis is typically completed by 36 weeks gestation; however, it is impacted by preterm birth. Early studies suggested that nephrogenesis persisted for ≤40 postnatal days in preterm infants. However, the postmenstrual age (PMA) of the preterm infants who survived >40 days was uncertain. In this study, we sought to reexamine postnatal kidney development in preterm infants surviving >40 days. METHODS: Human kidney samples were obtained from an institutional biobank...
February 2024: KI Reports
https://read.qxmd.com/read/38344732/an-initial-low-dose-etelcalcetide-dosing-strategy-in-hemodialysis-patients-with-moderate-secondary-hyperparathyroidism-is-effective-and-cost-saving
#42
JOURNAL ARTICLE
Andrea Carta, Martina Tedesco, Federica Mescia, Chiara Manenti, Bernardo Lucca, Federica Verzeletti, Alice Guerini, Federica Gaia Terni, Roberto Zubani, Simona Guerini, Brunella Valzorio, Guido Jeannin, Orsola Carli, Corrado Camerini, Stefano Possenti, Paola Gaggia, Federico Alberici
No abstract text is available yet for this article.
February 2024: KI Reports
https://read.qxmd.com/read/38344731/fertility-management-in-cystinosis-a-clinical-perspective
#43
REVIEW
Craig B Langman, Rowena B Delos Santos, Cybele Ghossein, Andrea M Atherton, Elena N Levtchenko, Aude Servais
Cystinosis is a rare, inherited, lysosomal storage disorder characterized by the progressive accumulation of intralysosomal cystine and subsequent organ and tissue damage. The kidneys are the first and most severely impacted organ. Although cystinosis was once considered a fatal pediatric disease, patients with cystinosis are living well into adulthood with advances in medical care, including kidney transplant and early and continuous use of cysteamine therapy. This increase in life expectancy has revealed an extrarenal phenotype of cystinosis that emerges in adolescence and adulthood, affecting nearly all body systems, including the endocrine and reproductive systems...
February 2024: KI Reports
https://read.qxmd.com/read/38344730/systematic-review-of-the-link-between-oxford-mest-c-classification-and-complement-activation-in-iga%C3%A2-nephropathy
#44
JOURNAL ARTICLE
Gabriel Ștefan, Eric Alamartine, Christophe Mariat, Nicolas Maillard
INTRODUCTION: IgA nephropathy's (IgAN's) MEST-C classification relationship with complement activation is still not fully understood because of limited and conflicting evidence. Our study aimed to delineate this relationship through a systematic review. METHODS: We adhered to the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines and conducted a systematic review, utilizing databases like MEDLINE (PubMed), Embase, Scopus, and Cochrane from January 2016 (year of updated MEST-C classification) to January 2023...
February 2024: KI Reports
https://read.qxmd.com/read/38344729/systematic-review-on-treatment-and-outcomes-of-tuberculous-peritonitis-in-patients-on-peritoneal-dialysis
#45
JOURNAL ARTICLE
Chau Wei Ling, Kamal Sud, Ronald L Castelino, David W Johnson, Trevor H Y Tan, Vincent W Lee
INTRODUCTION: Peritoneal dialysis (PD)-associated peritonitis due to tuberculosis (TB) is associated with poor outcomes and optimal treatment strategies for this condition remain unknown. Our study aimed to: (i) systematically review the published literature on peritonitis caused by Mycobacterium tuberculosis in patients on PD and (ii) review cases of peritonitis due to M tuberculosis in patients on PD reported in Australia and New Zealand to determine the epidemiology, management strategies, and outcomes of this condition...
February 2024: KI Reports
https://read.qxmd.com/read/38344728/randomized-trial-of-sglt2-inhibitor-identifies-target-proteins-in-diabetic-kidney-disease
#46
JOURNAL ARTICLE
Tarunveer S Ahluwalia, Teemu K E Rönkkö, Mie K Eickhoff, Viktor Rotbain Curovic, Justyna Siwy, Susanne Eder, Sara Denicolò, Gert Mayer, Harald Mischak, Peter Rossing, Frederik Persson
INTRODUCTION: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have emerged as novel therapeutics to treat diabetic kidney disease (DKD). Although the beneficial effects of SGLT2i have been demonstrated, their target mechanisms on kidney function are unknown. The current study aimed to elucidate these mechanisms by studying SGLT2i-induced changes in the urinary proteome of persons with type 2 diabetes (T2D) and DKD. METHODS: A total of 40 participants with T2D were enrolled in a double-blinded randomized cross-over trial at the Steno Diabetes Center Copenhagen, Denmark...
February 2024: KI Reports
https://read.qxmd.com/read/38344727/corrigendum-to-end-stage-renal-failure-patients-with-hemophilia-treated-with-peritoneal-dialysis-a-case-series-kidney-international-reports-volume-7-issue-12-december-2022-pages-2639-2646
#47
Hua Zheng, Haiyun Wang, Zijuan Zhou, Huacong Cai, Jing Liang, Yan Qin, Peng Xia, Limeng Chen
[This corrects the article DOI: 10.1016/j.ekir.2022.09.030.].
February 2024: KI Reports
https://read.qxmd.com/read/38344726/postnatal-nephrogenesis-in-preterm-infants-the-need-to-safeguard-kidney-development-after-birth
#48
EDITORIAL
Antonia C Nakatsugawa, Rosemary V Sampogna
No abstract text is available yet for this article.
February 2024: KI Reports
https://read.qxmd.com/read/38344725/the-prevalence-of-ckd-in-australian-primary-care-analysis-of-a-national-general-practice%C3%A2-dataset
#49
JOURNAL ARTICLE
Min Jun, James Wick, Brendon L Neuen, Sradha Kotwal, Sunil V Badve, Mark Woodward, John Chalmers, David Peiris, Anthony Rodgers, Kellie Nallaiah, Meg J Jardine, Vlado Perkovic, Martin Gallagher, Paul E Ronksley
INTRODUCTION: The prevalence of chronic kidney disease (CKD) in Australia varies substantially across reports. Using a large, nationally representative general practice data source, we determined the contemporary prevalence and staging of CKD in the Australian primary care. METHODS: We performed a retrospective, community-based observational study of 2,720,529 adults with ≥1 visit to a general practice participating in the MedicineInsight program and ≥1 serum creatinine measurement (with or without a urine albumin-to-creatinine ratio [UACR] measurement) between 2011 and 2020...
February 2024: KI Reports
https://read.qxmd.com/read/38344724/albuminuria-is-your-guide-to-assessing-future-gfr%C3%A2-slope
#50
EDITORIAL
Omar Al Dhaybi, George L Bakris
No abstract text is available yet for this article.
February 2024: KI Reports
https://read.qxmd.com/read/38344723/invasively-measured-aortic-systolic-blood-pressure-and-office-systolic-blood-pressure-in-cardiovascular-risk-assessment-in-ckd
#51
JOURNAL ARTICLE
Christian D Peters, Kevin K W Olesen, Esben Laugesen, Michael Mæng, Hans Erik Bøtker, Per L Poulsen, Niels Henrik Buus
INTRODUCTION: Central aortic blood pressure (BP) could be a better risk predictor than brachial BP. This study examined whether invasively measured aortic systolic BP improved outcome prediction beyond risk prediction by conventional cuff-based office systolic BP in patients with and without chronic kidney disease (CKD). METHODS: In a prospective, longitudinal cohort study, aortic and office systolic BPs were registered in patients undergoing elective coronary angiography (CAG)...
February 2024: KI Reports
https://read.qxmd.com/read/38344722/serum-galactomannan-a-predictor-of-poor-outcomes-in-peritoneal-dialysis-patients-with-fungal-peritonitis
#52
JOURNAL ARTICLE
Talerngsak Kanjanabuch, Tanawin Nopsopon, Thunvarat Saejew, Athiphat Banjongjit, Pongpratch Puapatanakul, Somkanya Tungsanga, Jakapat Vanichanan, Sajja Tatiyanupanwong, Kanjana Tianprasertkij, Worapot Treamtrakanpon, Uraiwan Parinyasiri, Kamol Khositrangsikun, Oranan Thamvichitkul, Pichet Lorvinitnun, Sriphrae Uppamai, Rhonachai Lawsuwanakul, Mananya Wanpaisitkul, Saowalak Chowpontong, Rutchanee Chieochanthanakij, Somchai Eiam-Ong, Jeffrey Perl, David W Johnson
INTRODUCTION: The potential value of serum galactomannan index (GMI) in monitoring treatment response in patients with fungal peritonitis who are receiving peritoneal dialysis (PD) was assessed in the present study. METHODS: The study included all Thailand fungal PD-related infectious complications surveillance (MycoPDICS) DATA study participants who had timely PD catheter removal and availability of both baseline and ≥2 subsequent serum GMI measurements after starting antifungal therapy (if available)...
February 2024: KI Reports
https://read.qxmd.com/read/38344721/implementation-of-a-1-day-living-kidney-donor-evaluation-program-a-qualitative-analysis-of-donor-candidate-and-stakeholder-perspectives
#53
JOURNAL ARTICLE
Lindsay Reid, Shreepriya Mangalgi, Gurraman Mann, Cynthiya Gnanaseelan, Natasha Hudek, Jamie Brehaut, Jessica McDougall, Heather Badenoch, Ariana Noel, Edward G Clark, Kevin D Burns, Greg Knoll, Manish Sood, Ann Bugeja
INTRODUCTION: A lengthy donor evaluation process hinders living donor kidney transplantation (LDKT). At The Ottawa Hospital, 1-day evaluation process was recently developed, with a goal to accelerate the determination of donor suitability. The major objective of this study was to solicit feedback from donor candidates and key stakeholders who participated in the 1-day living kidney donor evaluation process, to determine the program's acceptability and factors influencing its implementation elsewhere...
February 2024: KI Reports
https://read.qxmd.com/read/38344720/defining-nephritic-factors-as-diverse-drivers-of-systemic-complement-dysregulation-in-c3-glomerulopathy
#54
JOURNAL ARTICLE
Jill J Hauer, Yuzhou Zhang, Renee Goodfellow, Amanda Taylor, Nicole C Meyer, Sarah Roberts, Dingwu Shao, Lauren Fergus, Nicolo Ghiringhelli Borsa, Monica Hall, Carla M Nester, Richard J H Smith
INTRODUCTION: C3 glomerulopathy (C3G) is an ultrarare renal disease characterized by deposition of complement component C3 in the glomerular basement membrane (GBM). Rare and novel genetic variation in complement genes and autoantibodies to complement proteins are commonly identified in the C3G population and thought to drive the underlying complement dysregulation that results in renal damage. However, disease heterogeneity and rarity make accurately defining characteristics of the C3G population difficult...
February 2024: KI Reports
https://read.qxmd.com/read/38344719/green-nephrology-citrate-the-green-alternative-to-heparin-in-hemodialysis
#55
EDITORIAL
Jan van der Meulen
No abstract text is available yet for this article.
February 2024: KI Reports
https://read.qxmd.com/read/38344718/impact-of-remote-monitoring-on-standardized-outcomes-in-nephrology-peritoneal-dialysis
#56
JOURNAL ARTICLE
Francisco Javier Centellas-Pérez, Agustín Ortega-Cerrato, Manel Vera, Ramón Jesús Devesa-Buch, Eduardo Muñoz-de-Bustillo, Mercedes Prats, Rafael Alonso-Valente, José Pedro Morais, Paula Jaro Cara-Espada, Claudia Yuste-Lozano, Marco Montomoli, Miguel González-Rico, Beatriz Díez-Ojea, Francesc Barbosa, Miren Iriarte, Carmen Flores, Pedro Luís Quirós-Ganga, Laura Espinel, Vicente Paraíso, María Peña-Ortega, Diana Manzano, Bárbara Cancho, Juan Pérez-Martínez
INTRODUCTION: This study aimed to evaluate the association between the use of remote patient monitoring (RPM) in patients on automated peritoneal dialysis (APD) and the Standardized Outcomes in Nephrology in peritoneal dialysis (SONG-PD) clinical outcomes. METHODS: A prospective and multicenter cohort study was conducted on patients with advanced chronic kidney disease on APD, recruited at 16 Spanish Hospitals, between June 1 and December 31, 2021. Patients were divided into 2 cohorts, namely patients on APD with RPM (APD-RPM) and patients on APD without RPM...
February 2024: KI Reports
https://read.qxmd.com/read/38344717/clopidogrel-for-proteinuria-reduction-in%C3%A2-focal-segmental-glomerulosclerosis-phase-2-trial-design
#57
JOURNAL ARTICLE
Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, Kathrin Eller, Philipp Gauckler, Balazs Odler, Michael Rudnicki, Marcus D Säemann, Alice Schmidt, Gere Sunder-Plassmann, Martin Wiesholzer, Martin Windpessl, Emanuel Zitt, Franz Koenig, Larry A Greenbaum, Andreas Kronbichler, Christoph Aufricht
No abstract text is available yet for this article.
February 2024: KI Reports
https://read.qxmd.com/read/38344716/successful-kidney-transplantation-despite-ongoing-chronic-norovirus-infection
#58
Daan Kremer, Stefan P Berger, Erik A M Verschuuren, Stephan J L Bakker, Marjolein Knoester
No abstract text is available yet for this article.
February 2024: KI Reports
https://read.qxmd.com/read/38344715/autoantibodies-to-erythropoietin-receptor-and-clinical-outcomes-in-patients-with-type-2-diabetes-and-ckd-a-post-hoc-analysis-of-credence-trial
#59
JOURNAL ARTICLE
Akihiko Koshino, Brendon L Neuen, Megumi Oshima, Tadashi Toyama, Akinori Hara, Clare Arnott, Bruce Neal, Meg Jardine, Sunil V Badve, Kenneth W Mahaffey, Carol Pollock, Michael K Hansen, Takashi Wada, Hiddo J L Heerspink
INTRODUCTION: Autoantibodies to erythropoietin receptor (anti-EPOR antibodies) have been identified in patients with various kidney diseases. However, data in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) is limited. We assessed the prevalence of anti-EPOR antibodies and their association with clinical outcomes in this population. METHODS: The CREDENCE randomized patients with T2D and CKD to canagliflozin or placebo. Serum anti-EPOR antibodies, the exposure of interest, were measured using enzyme-linked immunosorbent assay...
February 2024: KI Reports
https://read.qxmd.com/read/38344714/lif-jak2-stat1-signaling-enhances-production-of-galactose-deficient-iga1-by-iga1-producing-cell-lines-derived-from-tonsils-of-patients-with-iga-nephropathy
#60
JOURNAL ARTICLE
Koshi Yamada, Zhi-Qiang Huang, Colin Reily, Todd J Green, Hitoshi Suzuki, Jan Novak, Yusuke Suzuki
INTRODUCTION: Galactose-deficient IgA1 (Gd-IgA1) plays a key role in the pathogenesis of IgA nephropathy (IgAN). Tonsillectomy has been beneficial to some patients with IgAN, possibly due to the removal of tonsillar cytokine-activated cells producing Gd-IgA1. To test this hypothesis, we used immortalized IgA1-producing cell lines derived from tonsils of patients with IgAN or obstructive sleep apnea (OSA) and assessed the effect of leukemia inhibitory factor (LIF) or oncostatin M (OSM) on Gd-IgA1 production...
February 2024: KI Reports
journal
journal
53651
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.